{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:46Z","timestamp":1787020666767,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI108368"],"award-info":[{"award-number":["R01AI108368"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The pressing need to expand the biomedical HIV prevention evidence base during pregnancy is now increasingly recognized. Women\u2019s views regarding participation in such trials and initiating PrEP while pregnant are critical to inform evolving policy and best practices aimed at responsibly expanding evidence-based access for this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted 35 semi-structured interviews with reproductive-aged women in Malawi in the local language, Chichewa. Participants were HIV-negative and purposively sampled to capture a range of experience with research during pregnancy. Women\u2019s perspectives on enrolling in three hypothetical HIV prevention trial vignettes while pregnant were explored, testing: (1) oral PrEP (Truvada) (2) a vaginal ring (dapivirine), and (3) a randomized trial comparing the two. The vignettes were read aloud to participants and a simple visual was provided. Interviews were audio-recorded, transcribed, translated, and coded using NVivo 11. Thematic analysis informed the analytic approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A majority of women accepted participation in all trials. Women\u2019s views on research participation varied largely based on their assessment of whether participation or nonparticipation would best protect their own health and that of their offspring. Women interested in participating described power dynamics with their partner as fueling their HIV exposure concerns and highlighted health benefits of participation\u2014principally, HIV protection and access to testing\/treatment and ancillary care, and perceived potential risks of the vignettes as low. Women who were uninterested in participating highlighted potential maternal and fetal health risks of the trial, challenges of justifying prevention use to their partner, and raised some modality-specific concerns. Women also described ways their social networks, sense of altruism and adherence requirements would influence participation decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The majority of participants conveyed strong interest in participating in biomedical HIV prevention research during pregnancy, largely motivated by a desire to protect themselves and their offspring. Our results are consistent with other studies that found high acceptance of HIV prevention products during pregnancy, and support the current direction of HIV research policies and practices that are increasingly aimed at protecting the health of pregnant women and their offspring through responsible research, rather than defaulting to their exclusion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12981-020-00271-6","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T05:02:48Z","timestamp":1590555768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Views among Malawian women about joining HIV prevention clinical trials when pregnant"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-078X","authenticated-orcid":false,"given":"Kristen","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiwonge","family":"Mtande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elana","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chifundo","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Faden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Drapkin","family":"Lyerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"271_CR1","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). UNAIDS 2017 Data. 2017."},{"issue":"1","key":"271_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/infdis\/jiy113","volume":"218","author":"KA Thomson","year":"2018","unstructured":"Thomson KA, Hughes J, Baeten JM, John-Stewart G, Celum C, Cohen CR, et al. Increased risk of HIV acquisition among women throughout pregnancy and during the postpartum period: a prospective per-coital-act analysis among women with HIV-infected partners. J Infect Dis. 2018;218(1):16\u201325.","journal-title":"J Infect Dis"},{"issue":"10","key":"271_CR3","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1097\/QAD.0b013e32832a5934","volume":"23","author":"D Moodley","year":"2009","unstructured":"Moodley D, Esterhuizen TM, Pather T, Chetty V, Ngaleka L. High HIV incidence during pregnancy: compelling reason for repeat HIV testing. AIDS. 2009;23(10):1255\u20139.","journal-title":"AIDS"},{"issue":"9492","key":"271_CR4","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(05)67481-8","volume":"366","author":"RH Gray","year":"2005","unstructured":"Gray RH, Li X, Kigozi G, Serwadda D, Brahmbhatt H, Wabwire-Mangen F, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet. 2005;366(9492):1182\u20138.","journal-title":"Lancet"},{"issue":"15","key":"271_CR5","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/QAD.0b013e32834a9338","volume":"25","author":"NR Mugo","year":"2011","unstructured":"Mugo NR, Heffron R, Donnell D, Wald A, Were EO, Rees H, et al. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. AIDS. 2011;25(15):1887\u201395.","journal-title":"AIDS"},{"issue":"13","key":"271_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-2393-13-57","volume":"4","author":"K Peltzer","year":"2013","unstructured":"Peltzer K, Mlambo G. Sexual HIV risk behaviour and associated factors among pregnant women in Mpumalanga, South Africa. BMC Pregnancy Childbirth. 2013;4(13):57.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"12","key":"271_CR7","doi-asserted-by":"publisher","first-page":"e115014","DOI":"10.1371\/journal.pone.0115014","volume":"9","author":"C De Schacht","year":"2014","unstructured":"De Schacht C, Hoffman HJ, Mabunda N, Lucas C, Alons CL, Madonela A, et al. High rates of HIV seroconversion in pregnant women and low reported levels of HIV testing among male partners in Southern Mozambique: results from a mixed methods study. PLoS ONE. 2014;9(12):e115014.","journal-title":"PLoS ONE"},{"issue":"12","key":"271_CR8","doi-asserted-by":"publisher","first-page":"e688","DOI":"10.1016\/S2352-3018(18)30316-3","volume":"5","author":"BA Tippett Barr","year":"2018","unstructured":"Tippett Barr BA, van Lettow M, van Oosterhout JJ, Landes M, Shiraishi RW, Amene E, et al. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis. Lancet HIV. 2018;5(12):e688\u201395.","journal-title":"Lancet HIV"},{"issue":"2","key":"271_CR9","doi-asserted-by":"publisher","first-page":"e1001608","DOI":"10.1371\/journal.pmed.1001608","volume":"11","author":"AL Drake","year":"2014","unstructured":"Drake AL, Wagner A, Richardson B, John-Stewart G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLoS Med. 2014;11(2):e1001608.","journal-title":"PLoS Med"},{"issue":"5","key":"271_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399\u2013410.","journal-title":"N Engl J Med"},{"issue":"5996","key":"271_CR11","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.1193748","volume":"329","author":"Q Abdool Karim","year":"2010","unstructured":"Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168\u201374.","journal-title":"Science"},{"issue":"4","key":"271_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.bpobgyn.2012.01.005","volume":"26","author":"S Sibeko","year":"2012","unstructured":"Sibeko S, Cohen GM, Moodley J. Contraception and pregnancy in microbicide trials. Best Pract Res Clin Obstet Gynaecol. 2012;26(4):473\u201386.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"271_CR13","unstructured":"Microbicide Trials Network, Sponsored by: Division of AIDS, US National Institute of Allergy and Infectious Diseases US National Institute of Child Health and Human Development US National Institute of Mental Health US National Institutes of Health. MTN-003: Phase 2B safety and effectiveness study of Tenofovir 1% Gel, Tenofovir Disoproxil Fumarate Tablet and Emtricitabine\/Tenofovir Disoproxil Fumarate Tablet for the Prevention of HIV Infection in Women. 2008."},{"issue":"1","key":"271_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.contraception.2010.06.012","volume":"83","author":"CA Schreiber","year":"2011","unstructured":"Schreiber CA, Whittington S, Cen L, Maslankowski L. Good intentions: risk factors for unintended pregnancies in the US cohort of a microbicide trial. Contraception. 2011;83(1):74\u201381.","journal-title":"Contraception"},{"issue":"6","key":"271_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1071\/SH18067","volume":"15","author":"N Davies","year":"2018","unstructured":"Davies N, Heffron R. Global and national guidance for the use of pre-exposure prophylaxis during peri-conception, pregnancy and breastfeeding. Sex Health. 2018;15(6):501\u201312.","journal-title":"Sex Health"},{"issue":"Suppl 1","key":"271_CR16","doi-asserted-by":"publisher","first-page":"21295","DOI":"10.7448\/IAS.20.2.21295","volume":"20","author":"DL Seidman","year":"2017","unstructured":"Seidman DL, Weber S, Cohan D. Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approach. J Int AIDS Soc. 2017;20(Suppl 1):21295.","journal-title":"J Int AIDS Soc"},{"key":"271_CR17","unstructured":"Dapivirine Vaginal Ring\u2014PrEPWatch. https:\/\/www.prepwatch.org\/nextgen-prep\/dapivirine-vaginal-ring\/. Accessed 3 Sept 2019."},{"issue":"5","key":"271_CR18","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/QAI.0000000000001861","volume":"79","author":"B Makanani","year":"2018","unstructured":"Makanani B, Balkus JE, Jiao Y, Noguchi LM, Palanee-Phillips T, Mbilizi Y, et al. Pregnancy and infant outcomes among women using the dapivirine vaginal ring in early pregnancy. J Acquir Immune Defic Syndr. 2018;79(5):566\u201372.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"271_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.wombi.2017.12.009","volume":"31","author":"ISE van der Zande","year":"2018","unstructured":"van der Zande ISE, van der Graaf R, Hooft L, van Delden JJM. Facilitators and barriers to pregnant women\u2019s participation in research: a systematic review. Women Birth. 2018;31(5):350\u201361.","journal-title":"Women Birth"},{"issue":"3","key":"271_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/QAI.0000000000001516","volume":"76","author":"J Pintye","year":"2017","unstructured":"Pintye J, Beima-Sofie KM, Kimemia G, Ngure K, Trinidad SB, Heffron RA, et al. \u201cI Did not want to give birth to a child who has HIV\u201d: experiences using PrEP during pregnancy among HIV-uninfected Kenyan women in HIV-serodiscordant couples. JAIDS J Acquir Immune Defic Syndr. 2017;76(3):259.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"271_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1089\/apc.2018.0058","volume":"32","author":"J Pintye","year":"2018","unstructured":"Pintye J, Beima-Sofie KM, Makabong\u2019O PA, Njoroge A, Trinidad SB, Heffron RA, et al. HIV-uninfected Kenyan adolescent and young women share perspectives on using preexposure prophylaxis during pregnancy. AIDS Patient Care STDS. 2018;32:538\u201344.","journal-title":"AIDS Patient Care STDS"},{"issue":"5","key":"271_CR22","doi-asserted-by":"publisher","first-page":"e0197143","DOI":"10.1371\/journal.pone.0197143","volume":"13","author":"D Joseph Davey","year":"2018","unstructured":"Joseph Davey D, Farley E, Towriss C, Gomba Y, Bekker L-G, Gorbach P, et al. Risk perception and sex behaviour in pregnancy and breastfeeding in high HIV prevalence settings: programmatic implications for PrEP delivery. PLoS ONE. 2018;13(5):e0197143.","journal-title":"PLoS ONE"},{"issue":"Suppl 3","key":"271_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12978-017-0424-0","volume":"14","author":"K Ngure","year":"2017","unstructured":"Ngure K, Trinidad SB, Beima-Sofie K, Baeten JM, Mugo NR, Bukusi EA, et al. The role of male partners in women\u2019s participation in research during pregnancy: a case study from the partners demonstration project. Reprod Health. 2017;14(Suppl 3):160.","journal-title":"Reprod Health"},{"key":"271_CR24","volume-title":"Programmatic update: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: executive summary","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Programmatic update: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: executive summary. Geneva: World Health Organization; 2012."},{"key":"271_CR25","unstructured":"UNAIDS. Malawi: results. https:\/\/www.unaids.org\/en\/regionscountries\/countries\/malawi. Accessed 14 May 2019."},{"key":"271_CR26","unstructured":"The World Bank. Fertility rate, total (births per woman)| Data. https:\/\/data.worldbank.org\/indicator\/SP.DYN.TFRT.IN?locations=MW. Accessed 14 May 2019."},{"issue":"4","key":"271_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/1556264618783834","volume":"13","author":"KA Sullivan","year":"2018","unstructured":"Sullivan KA, Little M, Rosenberg NE, Mtande T, Zimba C, Jaffe E, et al. Women\u2019s views about a paternal consent requirement for biomedical research in pregnancy. J Empir Res Hum Res Ethics. 2018;13(4):349\u201362.","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"15","key":"271_CR28","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1097\/QAD.0000000000001214","volume":"30","author":"CB Krubiner","year":"2016","unstructured":"Krubiner CB, Faden RR, Cadigan RJ, Gilbert SZ, Henry LM, Little MO, et al. Advancing HIV research with pregnant women: navigating challenges and opportunities. AIDS. 2016;30(15):2261\u20135.","journal-title":"AIDS"},{"key":"271_CR29","doi-asserted-by":"publisher","DOI":"10.4135\/9781506374680","volume-title":"Collecting qualitative data: a field manual for applied research","author":"G Guest","year":"2013","unstructured":"Guest G, Namey EE, Mitchell ML. Collecting qualitative data: a field manual for applied research. Thousand Oaks: SAGE Publications, Ltd; 2013."},{"key":"271_CR30","volume-title":"Basics of qualitative research techniques","author":"A Strauss","year":"1998","unstructured":"Strauss A, Corbin J. Basics of qualitative research techniques. Thousand Oaks: Sage publications; 1998."},{"key":"271_CR31","unstructured":"Malawi\u2014PrEPWatch. https:\/\/www.prepwatch.org\/country\/malawi\/. Accessed 10 May 2019."},{"key":"271_CR32","unstructured":"Rennie S, Sugarman J, HPTN Ethics Working Group. HIV prevention trials network ethics guidance for research. 2009."},{"issue":"9482","key":"271_CR33","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0140-6736(05)66992-9","volume":"366","author":"EJ Emanuel","year":"2005","unstructured":"Emanuel EJ, Currie XE, Herman A, Project Phidisa. Undue inducement in clinical research in developing countries: is it a worry? Lancet. 2005;366(9482):336\u201340.","journal-title":"Lancet"},{"issue":"12","key":"271_CR34","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1136\/medethics-2016-103414","volume":"43","author":"KT Mngadi","year":"2017","unstructured":"Mngadi KT, Singh JA, Mansoor LE, Wassenaar DR. Undue inducement: a case study in CAPRISA 008. J Med Ethics. 2017;43(12):824\u20138.","journal-title":"J Med Ethics"},{"key":"271_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.01.011","author":"CB Krubiner","year":"2019","unstructured":"Krubiner CB, Faden RR, Karron RA, Little MO, Lyerly AD, Abramson JS, et al. Pregnant women & vaccines against emerging epidemic threats: ethics guidance for preparedness, research, and response. Vaccine. 2019. https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.011.","journal-title":"Vaccine"},{"issue":"2","key":"271_CR36","first-page":"37","volume":"20","author":"J Mfutso-Bengo","year":"2008","unstructured":"Mfutso-Bengo J, Ndebele P, Jumbe V, Mkunthi M, Masiye F, Molyneux S, et al. Why do individuals agree to enrol in clinical trials? A qualitative study of health research participation in Blantyre, Malawi. Malawi Med J. 2008;20(2):37\u201341.","journal-title":"Malawi Med J"},{"key":"271_CR37","doi-asserted-by":"crossref","unstructured":"Participants in 2006 Georgetown University Workshop on Ancillary-Care Obligations of Medical Researchers Working in Developing Countries. The ancillary-care obligations of medical researchers working in developing countries. PLoS Med. 2008;5(5):e90.","DOI":"10.1371\/journal.pmed.0050090"},{"issue":"3 Spec No","key":"271_CR38","first-page":"135","volume":"18","author":"BG Haire","year":"2014","unstructured":"Haire BG, Ogundokun O. Ethics of ancillary care in clinical trials in low income countries: a Nigerian case study. Afr J Reprod Health. 2014;18(3 Spec No):135\u201342.","journal-title":"Afr J Reprod Health"},{"issue":"4","key":"271_CR39","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1353\/ken.2011.0019","volume":"21","author":"MW Merritt","year":"2011","unstructured":"Merritt MW. Health researchers\u2019 ancillary care obligations in low-resource settings: how can we tell what is morally required? Kennedy Inst Ethics J. 2011;21(4):311\u201347.","journal-title":"Kennedy Inst Ethics J"},{"issue":"1","key":"271_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1556264614559888","volume":"10","author":"J Mfutso-Bengo","year":"2015","unstructured":"Mfutso-Bengo J, Manda-Taylor L, Masiye F. Motivational factors for participation in biomedical research: evidence from a qualitative study of biomedical research participation in Blantyre District, Malawi. J Empir Res Hum Res Ethics. 2015;10(1):59\u201364.","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"2","key":"271_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/23294515.2016.1271062","volume":"8","author":"LW Roberts","year":"2017","unstructured":"Roberts LW, Kim JP. Healthy individuals\u2019 perspectives on clinical research protocols and influences on enrollment decisions. AJOB Empir Bioeth. 2017;8(2):89\u201398.","journal-title":"AJOB Empir Bioeth"},{"issue":"6","key":"271_CR42","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509\u201318.","journal-title":"N Engl J Med"},{"issue":"5","key":"271_CR43","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411\u201322.","journal-title":"N Engl J Med"},{"issue":"1","key":"271_CR44","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12879-018-3463-4","volume":"18","author":"D Sidebottom","year":"2018","unstructured":"Sidebottom D, Ekstr\u00f6m AM, Str\u00f6mdahl S. A systematic review of adherence to oral pre-exposure prophylaxis for HIV\u2014how can we improve uptake and adherence? BMC Infect Dis. 2018;18(1):581.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"271_CR45","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199709183371212","volume":"337","author":"P Lurie","year":"1997","unstructured":"Lurie P, Wolfe SM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med. 1997;337(12):853\u20136.","journal-title":"N Engl J Med"},{"issue":"4","key":"271_CR46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2105\/AJPH.88.4.564","volume":"88","author":"SS Abdool Karim","year":"1998","unstructured":"Abdool Karim SS. Placebo controls in HIV perinatal transmission trials: a South African\u2019s viewpoint. Am J Public Health. 1998;88(4):564\u20136.","journal-title":"Am J Public Health"},{"issue":"3 Pt 2","key":"271_CR47","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.ajog.2005.06.020","volume":"193","author":"LB McCullough","year":"2005","unstructured":"McCullough LB, Coverdale JH, Chervenak FA. A comprehensive ethical framework for responsibly designing and conducting pharmacologic research that involves pregnant women. Am J Obstet Gynecol. 2005;193(3 Pt 2):901\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"271_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1055\/s-2003-38318","volume":"20","author":"MA Rodger","year":"2003","unstructured":"Rodger MA, Makropoulos D, Walker M, Keely E, Karovitch A, Wells PS. Participation of pregnant women in clinical trials: will they participate and why? Am J Perinatol. 2003;20(2):69\u201376.","journal-title":"Am J Perinatol"},{"issue":"15","key":"271_CR49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12884-015-0641-x","volume":"4","author":"K Oude Rengerink","year":"2015","unstructured":"Oude Rengerink K, Logtenberg S, Hooft L, Bossuyt PM, Mol BW. Pregnant womens\u2019 concerns when invited to a randomized trial: a qualitative case control study. BMC Pregnancy Childbirth. 2015;4(15):207.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"271_CR50","first-page":"1","volume":"34","author":"AD Lyerly","year":"2012","unstructured":"Lyerly AD, Namey EE, Gray B, Swamy G, Faden RR. Women\u2019s views about participating in research while pregnant. IRB Ethics Hum Res. 2012;34(4):1.","journal-title":"IRB Ethics Hum Res"},{"issue":"1","key":"271_CR51","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1016\/j.whi.2012.10.003","volume":"23","author":"MC Blehar","year":"2013","unstructured":"Blehar MC, Spong C, Grady C, Goldkind SF, Sahin L, Clayton JA. Enrolling pregnant women: issues in clinical research. Womens Health Issues. 2013;23(1):e39\u201345.","journal-title":"Womens Health Issues"},{"issue":"59 Suppl 7","key":"271_CR52","doi-asserted-by":"publisher","first-page":"S400","DOI":"10.1093\/cid\/ciu726","volume":"15","author":"PM Frew","year":"2014","unstructured":"Frew PM, Saint-Victor DS, Isaacs MB, Kim S, Swamy GK, Sheffield JS, et al. Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices. Clin Infect Dis. 2014;15(59 Suppl 7):S400\u20137.","journal-title":"Clin Infect Dis"},{"key":"271_CR53","unstructured":"MTN-042 Microbicide Trials Network. https:\/\/mtnstopshiv.org\/research\/studies\/mtn-042. Accessed 16 May 2019."},{"key":"271_CR54","unstructured":"IMPAACT 2009. https:\/\/impaactnetwork.org\/studies\/IMPAACT2009.asp. Accessed 16 May 2019."},{"key":"271_CR55","unstructured":"MTN-041 Microbicide Trials Network. https:\/\/mtnstopshiv.org\/research\/studies\/mtn-041. Accessed 16 May 2019."},{"issue":"4","key":"271_CR56","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/COH.0000000000000168","volume":"10","author":"C Trezza","year":"2015","unstructured":"Trezza C, Ford SL, Spreen W, Pan R, Piscitelli S. Formulation and pharmacology of long-acting cabotegravir. Curr Opin HIV AIDS. 2015;10(4):239\u201345.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"271_CR57","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1038\/s41467-018-06490-w","volume":"9","author":"M Kovarova","year":"2018","unstructured":"Kovarova M, Benhabbour SR, Massud I, Spagnuolo RA, Skinner B, Baker CE, et al. Ultra-long-acting removable drug delivery system for HIV treatment and prevention. Nat Commun. 2018;9(1):4156.","journal-title":"Nat Commun"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-020-00271-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-020-00271-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-020-00271-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T19:45:42Z","timestamp":1622058342000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-020-00271-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["271"],"URL":"https:\/\/doi.org\/10.1186\/s12981-020-00271-6","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"assertion":[{"value":"26 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research was approved by the institutional review board at the University of North Carolina (UNC) at Chapel Hill, and the National Health Science Research Committee of Malawi. All participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}